NASDAQ:RPRX
Royalty Pharma plc Stock News
$27.27
-0.610 (-2.19%)
At Close: May 17, 2024
Royalty Pharma plc (RPRX) Q3 2022 Results - Earnings Call Transcript
10:40am, Tuesday, 08'th Nov 2022
Royalty Pharma plc (NASDAQ:RPRX ) Q3 2022 Results Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants George Grofik - SVP, Head, IR & Communications Pablo Legorreta - Founder and
Royalty Pharma (RPRX) Surpasses Q3 Earnings and Revenue Estimates
09:48am, Tuesday, 08'th Nov 2022
Royalty Pharma (RPRX) delivered earnings and revenue surprises of 2.82% and 3.28%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Royalty Pharma (RPRX)
09:47am, Monday, 07'th Nov 2022
Royalty Pharma (RPRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Royalty Pharma (RPRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:19am, Tuesday, 01'st Nov 2022
Royalty Pharma (RPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Royalty Pharma to Announce Third Quarter 2022 Financial Results on November 8, 2022
08:30am, Tuesday, 18'th Oct 2022
NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2022 financial results on Tuesday, November 8, 2022 before the U.S.
Royalty Pharma to Present at Upcoming Investor Conferences
04:15pm, Tuesday, 06'th Sep 2022
NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of September:
These Are the 6 Stocks Warren Buffett Sold in the Second Quarter
05:30am, Saturday, 20'th Aug 2022
Buffett and his company Berkshire Hathaway sold $2.3 billion of its equity holdings in the second quarter of the year.
Three Stock Lunch: Ally Financial, Amazon and Royalty Pharma
03:46pm, Tuesday, 16'th Aug 2022
Eva Ados, ERShares chief investment strategist, joins 'Power Lunch' to discuss her take on three stocks: Ally Financial, Amazon and Royalty Pharma.
Warren Buffett Ramps Up Occidental and Apple Stakes, Dumps Verizon
06:35pm, Monday, 15'th Aug 2022
Warren Buffett (Trades, Portfolio)'s multibillion-dollar conglomerate, Berkshire Hathaway Inc. ( BRK.A , Financial)( BRK.B , Financial), disclosed its equity portfolio for the second quarter of 2022 o
Buffett's Berkshire more than triples Ally stake, sheds Verizon
04:46pm, Monday, 15'th Aug 2022
Warren Buffett's Berkshire Hathaway Inc on Monday said it more than tripled its stake in the online banking company Ally Financial Inc, while shedding its stakes in Verizon Communications Inc and Roya
Royalty Pharma's (RPRX) CEO Pablo Legorreta on Q2 2022 Results - Earnings Call Transcript
02:09pm, Thursday, 04'th Aug 2022
Royalty Pharma plc (NASDAQ:RPRX ) Q2 2022 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants George Grofik - SVP, Head, IR & Communications Pablo Legorreta - Founder & CEO Marshal
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates
10:32am, Thursday, 04'th Aug 2022
Royalty Pharma (RPRX) delivered earnings and revenue surprises of 1.28% and 2.37%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:47am, Thursday, 28'th Jul 2022
Royalty Pharma (RPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Blueprint inks deal with Sixth Street, Royalty Pharma worth up to $1.2 billion
08:42am, Thursday, 30'th Jun 2022
Shares of Blueprint Medicines Corp. BPMC, -2.34% gained 3.3% in premarket trading on Thursday after the company announced a deal with investment firm Sixth Street and Royalty Pharma RPRX, -1.10% , whi
Royalty Pharma (RPRX) Surges 5.2%: Is This an Indication of Further Gains?
07:42am, Monday, 27'th Jun 2022
Royalty Pharma (RPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incre
